Imeglimin to the Rescue: Enhanced CHOP/GADD34/ eIF2a Signaling Axis Promotes β-Cell Survival

Seokwon Jo; Emilyn U. Alejandro

doi:10.2337/dbi21-0035

Imeglimin to the Rescue: Enhanced CHOP/GADD34/ eIF2a Signaling Axis Promotes β-Cell Survival

Physiology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	376-378
Number of pages	3
Journal	Diabetes
Volume	71
Issue number	3
DOIs	https://doi.org/10.2337/dbi21-0035
State	Published - Mar 2022

Bibliographical note

Funding Information:
Funding. Work in the E.U.A. laboratory is supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease (R01 DK115720), National Institute of Child Health and Human Development (R21 HD100840), and the McKnight Foundation. Duality of Interest. No potential conflicts of interest relevant to this article were reported.

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.2337/dbi21-0035

Find It

Find It at U of M Libraries

Cite this

@article{61297b45fd17449a9aeb2b2fe6d6682d,

title = "Imeglimin to the Rescue: Enhanced CHOP/GADD34/ eIF2a Signaling Axis Promotes β-Cell Survival",

author = "Seokwon Jo and Alejandro, {Emilyn U.}",

note = "Funding Information: Funding. Work in the E.U.A. laboratory is supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease (R01 DK115720), National Institute of Child Health and Human Development (R21 HD100840), and the McKnight Foundation. Duality of Interest. No potential conflicts of interest relevant to this article were reported.",

year = "2022",

month = mar,

doi = "10.2337/dbi21-0035",

language = "English (US)",

volume = "71",

pages = "376--378",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

number = "3",

}

TY - JOUR

T1 - Imeglimin to the Rescue

T2 - Enhanced CHOP/GADD34/ eIF2a Signaling Axis Promotes β-Cell Survival

AU - Jo, Seokwon

AU - Alejandro, Emilyn U.

N1 - Funding Information: Funding. Work in the E.U.A. laboratory is supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease (R01 DK115720), National Institute of Child Health and Human Development (R21 HD100840), and the McKnight Foundation. Duality of Interest. No potential conflicts of interest relevant to this article were reported.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85125155648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125155648&partnerID=8YFLogxK

U2 - 10.2337/dbi21-0035

DO - 10.2337/dbi21-0035

M3 - Editorial

C2 - 35196391

AN - SCOPUS:85125155648

SN - 0012-1797

VL - 71

SP - 376

EP - 378

JO - Diabetes

JF - Diabetes

IS - 3

ER -

Imeglimin to the Rescue: Enhanced CHOP/GADD34/ eIF2a Signaling Axis Promotes β-Cell Survival

Bibliographical note

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Cite this